{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T09:34:18Z","timestamp":1790760858021,"version":"4.1.0"},"reference-count":32,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,21]],"date-time":"2022-12-21T00:00:00Z","timestamp":1671580800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100012737","name":"Department of Health and Human Services, State Government of Victoria","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012737","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["1138466"],"award-info":[{"award-number":["1138466"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["2021901444"],"award-info":[{"award-number":["2021901444"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004752","name":"State Government of Victoria","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004752","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008018","name":"Victorian Cancer Agency","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008018","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical and Biophysical Research Communications"],"published-print":{"date-parts":[[2023,1]]},"DOI":"10.1016\/j.bbrc.2022.12.053","type":"journal-article","created":{"date-parts":[[2022,12,20]],"date-time":"2022-12-20T11:06:58Z","timestamp":1671534418000},"page":"162-166","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["Serum Neu5Gc biomarkers are elevated in primary cutaneous melanoma"],"prefix":"10.1016","volume":"642","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8847-0503","authenticated-orcid":false,"given":"Lucy K.","family":"Shewell","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7953-4408","authenticated-orcid":false,"given":"Christopher J.","family":"Day","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2145-2685","authenticated-orcid":false,"given":"Tiana","family":"Hippolite","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xavier","family":"De Bisscop","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James C.","family":"Paton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrienne W.","family":"Paton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael P.","family":"Jennings","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbrc.2022.12.053_bib1","article-title":"Epidemiology of melanoma","volume":"9","author":"Saginala","year":"2021","journal-title":"Med. Sci."},{"key":"10.1016\/j.bbrc.2022.12.053_bib2","first-page":"7","article-title":"Cancer statistics, 2021","volume":"71","author":"Siegel","year":"2021","journal-title":"CA A Cancer J. Clin."},{"key":"10.1016\/j.bbrc.2022.12.053_bib3","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1067\/mjd.2003.281","article-title":"Dermoscopy of pigmented skin lesions: results of a consensus meeting via the Internet","volume":"48","author":"Argenziano","year":"2003","journal-title":"J.\u00a0Am. Acad. Dermatol."},{"key":"10.1016\/j.bbrc.2022.12.053_bib4","doi-asserted-by":"crossref","first-page":"6199","DOI":"10.1200\/JCO.2009.23.4799","article-title":"Final version of 2009 AJCC melanoma staging and classification","volume":"27","author":"Balch","year":"2009","journal-title":"J.\u00a0Clin. Oncol."},{"key":"10.1016\/j.bbrc.2022.12.053_bib5","first-page":"851","article-title":"Diversity in cell surface sialic acid presentations: implications for biology and disease, Laboratory investigation","volume":"87","author":"Varki","year":"2007","journal-title":"J.\u00a0Tech. Methods Pathol."},{"key":"10.1016\/j.bbrc.2022.12.053_bib6","doi-asserted-by":"crossref","first-page":"11736","DOI":"10.1073\/pnas.182257399","article-title":"Inactivation of CMP-N-acetylneuraminic acid hydroxylase occurred prior to brain expansion during human evolution","volume":"99","author":"Chou","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.bbrc.2022.12.053_bib7","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1002\/bmc.573","article-title":"Determination and distribution of N-acetyl- and N-glycolylneuraminic acids in culture media and cell-associated glycoconjugates from human malignant mesothelioma and adenocarcinoma cells, Biomedical chromatography","volume":"20","author":"Tzanakakis","year":"2006","journal-title":"BMC (Biomed. Chromatogr.)"},{"key":"10.1016\/j.bbrc.2022.12.053_bib8","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/S0300-9084(01)01303-7","article-title":"N-Glycolylneuraminic acid in human tumours","volume":"83","author":"Malykh","year":"2001","journal-title":"Biochimie"},{"key":"10.1016\/j.bbrc.2022.12.053_bib9","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1093\/glycob\/cwq030","article-title":"Extensive enrichment of N-glycolylneuraminic acid in extracellular sialoglycoproteins abundantly synthesized and secreted by human cancer cells","volume":"20","author":"Inoue","year":"2010","journal-title":"Glycobiology"},{"key":"10.1016\/j.bbrc.2022.12.053_bib10","first-page":"33","article-title":"Involvement of a non-human sialic Acid in human cancer","volume":"4","author":"Samraj","year":"2014","journal-title":"Front. Oncol."},{"key":"10.1016\/j.bbrc.2022.12.053_bib11","first-page":"3796","article-title":"Characterization of N-glycolylneuraminic acid-containing gangliosides as tumor-associated Hanganutziu-Deicher antigen in human colon cancer","volume":"45","author":"Higashi","year":"1985","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbrc.2022.12.053_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbadis.2022.166493","article-title":"Lamprey immunity protein enables early detection and recurrence monitoring for bladder cancer through recognizing Neu5Gc-modified uromodulin glycoprotein in urine","volume":"1868","author":"Teng","year":"2022","journal-title":"Biochim. Biophys. Acta, Mol. Basis Dis."},{"key":"10.1016\/j.bbrc.2022.12.053_bib13","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1038\/s41598-017-01522-9","article-title":"Structure aided design of a Neu5Gc specific lectin","volume":"7","author":"Day","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbrc.2022.12.053_bib14","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/j.bbrc.2018.04.151","article-title":"Specificity and utility of SubB2M, a new N-glycolylneuraminic acid lectin","volume":"500","author":"Wang","year":"2018","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbrc.2022.12.053_bib15","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1038\/nature07428","article-title":"Incorporation of a non-human glycan mediates human susceptibility to a bacterial toxin","volume":"456","author":"Byres","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.bbrc.2022.12.053_bib16","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1084\/jem.20040392","article-title":"A\u00a0new family of potent AB(5) cytotoxins produced by Shiga toxigenic Escherichia coli","volume":"200","author":"Paton","year":"2004","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.bbrc.2022.12.053_bib17","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.bbrc.2018.11.001","article-title":"Detection of N-glycolylneuraminic acid biomarkers in sera from patients with ovarian cancer using an engineered N-glycolylneuraminic acid-specific lectin SubB2M","volume":"507","author":"Shewell","year":"2018","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbrc.2022.12.053_bib18","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1186\/s12885-022-09428-0","article-title":"N-glycolylneuraminic acid serum biomarker levels are elevated in breast cancer patients at all stages of disease","volume":"22","author":"Shewell","year":"2022","journal-title":"BMC Cancer"},{"key":"10.1016\/j.bbrc.2022.12.053_bib19","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1016\/S0140-6736(13)60802-8","article-title":"Cutaneous melanoma","volume":"383","author":"Eggermont","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.bbrc.2022.12.053_bib20","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1126\/science.1253735","article-title":"The melanoma revolution: from UV carcinogenesis to a new era in therapeutics","volume":"346","author":"Lo","year":"2014","journal-title":"Science"},{"key":"10.1016\/j.bbrc.2022.12.053_bib21","first-page":"472","article-title":"Members of the American Joint committee on cancer melanoma expert, D. The international melanoma, P. Discovery, melanoma staging: evidence-based changes in the American Joint committee on cancer eighth edition cancer staging manual","volume":"67","author":"Gershenwald","year":"2017","journal-title":"CA A Cancer J. Clin."},{"key":"10.1016\/j.bbrc.2022.12.053_bib22","doi-asserted-by":"crossref","first-page":"500","DOI":"10.5858\/arpa.2019-0561-RA","article-title":"The 2018 world Health organization classification of cutaneous, mucosal, and uveal melanoma: detailed analysis of 9 distinct subtypes defined by their evolutionary pathway","volume":"144","author":"Elder","year":"2020","journal-title":"Arch. Pathol. Lab Med."},{"key":"10.1016\/j.bbrc.2022.12.053_bib23","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1002\/ijc.2910440127","article-title":"Ganglioside GD3 shedding by human malignant melanoma cells","volume":"44","author":"Bernhard","year":"1989","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.bbrc.2022.12.053_bib24","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1002\/1878-0261.12702","article-title":"Upregulation of cell surface GD3 ganglioside phenotype is associated with human melanoma brain metastasis","volume":"14","author":"Ramos","year":"2020","journal-title":"Mol Oncol"},{"key":"10.1016\/j.bbrc.2022.12.053_bib25","doi-asserted-by":"crossref","first-page":"3029","DOI":"10.1002\/1097-0142(19910615)67:12<3029::AID-CNCR2820671217>3.0.CO;2-8","article-title":"Ganglioside GM3:GD3 ratio as an index for the management of melanoma","volume":"67","author":"Ravindranath","year":"1991","journal-title":"Cancer"},{"key":"10.1016\/j.bbrc.2022.12.053_bib26","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/0006-291X(84)91282-8","article-title":"Gangliosides of normal and neoplastic human melanocytes","volume":"120","author":"Carubia","year":"1984","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbrc.2022.12.053_bib27","doi-asserted-by":"crossref","first-page":"11041","DOI":"10.1073\/pnas.0503658102","article-title":"Ganglioside GD3 promotes cell growth and invasion through p130Cas and paxillin in malignant melanoma cells","volume":"102","author":"Hamamura","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.bbrc.2022.12.053_bib28","doi-asserted-by":"crossref","first-page":"27213","DOI":"10.1074\/jbc.M109.087791","article-title":"Ganglioside GD3 enhances adhesion signals and augments malignant properties of melanoma cells by recruiting integrins to glycolipid-enriched microdomains","volume":"285","author":"Ohkawa","year":"2010","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.bbrc.2022.12.053_bib29","doi-asserted-by":"crossref","DOI":"10.5402\/2011\/848909","article-title":"Immunohistochemical reactivity of the 14F7 monoclonal antibody raised against N-glycolyl GM3 ganglioside in some benign and malignant skin neoplasms","author":"Blanco","year":"2011","journal-title":"ISRN Dermatol."},{"key":"10.1016\/j.bbrc.2022.12.053_bib30","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1089\/02724570050109639","article-title":"A\u00a0mouse IgG1 monoclonal antibody specific for N-glycolyl GM3 ganglioside recognized breast and melanoma tumors","volume":"19","author":"Carr","year":"2000","journal-title":"Hybridoma"},{"key":"10.1016\/j.bbrc.2022.12.053_bib31","doi-asserted-by":"crossref","first-page":"488","DOI":"10.4161\/cbt.7.4.5476","article-title":"Heterophilic NeuGcGM3 ganglioside cancer vaccine in advanced melanoma patients: results of a Phase Ib\/IIa study","volume":"7","author":"Osorio","year":"2008","journal-title":"Cancer Biol. Ther."},{"key":"10.1016\/j.bbrc.2022.12.053_bib32","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1186\/1471-2407-14-560","article-title":"Molecular subtyping of metastatic melanoma based on cell ganglioside metabolism profiles","volume":"14","author":"Tringali","year":"2014","journal-title":"BMC Cancer"}],"container-title":["Biochemical and Biophysical Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X22017181?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X22017181?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T18:37:47Z","timestamp":1777401467000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006291X22017181"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1]]},"references-count":32,"alternative-id":["S0006291X22017181"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrc.2022.12.053","relation":{},"ISSN":["0006-291X"],"issn-type":[{"value":"0006-291X","type":"print"}],"subject":[],"published":{"date-parts":[[2023,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Serum Neu5Gc biomarkers are elevated in primary cutaneous melanoma","name":"articletitle","label":"Article Title"},{"value":"Biochemical and Biophysical Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbrc.2022.12.053","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}